Drug intelligence / Profile preview

ERWOmun immun akut

Development stage
Unknown
Lead developer
ERWO Pharma
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

ERWOmun immun akut is a food for special medical purposes (balanced diet) developed by ERWO Pharma for the dietary management of flu-like infections and increased susceptibility to infections. The formulation contains a high-dose combination of essential micronutrients, including Vitamin C, Vitamin D3, Zinc, and Selenium, supplemented with citrus bioflavonoids. These components are intended to support the immune system's function during acute viral challenges and provide antioxidant protection against oxidative stress. As a medical food, it is designed to meet the specific nutritional requirements of patients whose dietary needs cannot be met through a standard diet alone during illness.

Brand names
ERWOmun immun akut
Other names
ERWOmun
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on ERWOmun immun akut.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ERWOmun immun akut.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call